Le Lézard

News by subject: TRI

1 2 3 4 5 6 7 8 9 10

Today

15:21
On January 24, the Tuberous Sclerosis Alliance (TS Alliance) learned the US Food and Drug Administration (FDA) formally approved Lundbeck Pharmaceutical's label expansion for Sabril® (vigabatrin) to now be available to treat refractory complex...

15:15
The Harrington Discovery Institute® at University Hospitals in Cleveland, Ohio, and its registered UK charity Fund for Cures UK, Ltd. (Fund for Cures UK) have issued a call for proposals for the 2020 Harrington UK Rare Disease Scholar Award, a new...

15:00
On Target Laboratories, Inc., a privately-held biotechnology company developing the use of fluorescent markers to target and illuminate cancer during surgery, has announced the results of a multi-institutional Phase 2 clinical trial in which outcomes...

12:13
The Mayo Clinic estimates 75 percent of menstruating women experience PMS (premenstrual syndrome), many of who experience Emotional PMS, a subset of psychological symptoms including anxiety, stress, irritability and mood swings in the weeks or days...

11:29
The National Advertising Division determined that Elysium Health, Inc. had submitted evidence sufficient to reasonably demonstrate that nicotinamide adenine dinucleotide ("NAD+") plays a key role in cellular metabolism and mitochondrial health, and...

11:00
Many cells are covered with mysterious large holes, pores that have been associated with the sense of taste as well as Alzheimer's disease, depression, and even asthma. Knowing the structure of these varied holes will help researchers better...

10:30
On January 23, The Geneva based Anti-Coronavirus Foundation announced that it will raise funds among crypto enthusiasts for the further financing of a vaccine against coronavirus. The outbreak of a new coronavirus in China has killed at least 17...

09:00
An estimated 228,150 Americans are diagnosed with lung cancer every year?one every four minutes?making it one of the most common cancers. It also one of the deadliest cancers. The high mortality rate associated with lung cancer is in part because its...

08:58
Saluda Medical Pty Limited ("Saluda Medical") today announced that new data, from multiple studies evaluating the company's Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System for the treatment of chronic pain, were presented in...

08:36
ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced dosing of the first patient in a Phase 1b clinical trial being conducted under...

08:36
Patients with Lewy body dementia may be eligible for a study of a treatment that was found to be effective in Alzheimer's disease, according to results of ongoing studies. Pacific Neuroscience Institute, which is affiliated with Providence Saint...

08:35
The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced plans to evaluate futibatinib (TAS-120), a potent and selective inhibitor of the fibroblast growth factor receptor (FGFR). The project will include...

08:25
Cannabics Pharmaceuticals Inc. , a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that in a series of tests conducted at the company's High Through-put Screening (HTS) facility in Israel, it has...

08:15
PharmaMar (PHM:MSE) and Bionical Emas, a global specialist Clinical Research Organization (CRO) have today announced the launch of an Expanded Access Program (EAP) for lurbinectedin to treat patients in the United States (U.S.) with relapsed Small...

08:05
Functional solutions that help you achieve antibiotic-free production: that is the promise German-based attendee EW Nutrition makes at this year's IPPE. Recognizing that the challenges of antimicrobial resistance are now spilling from animal...

08:00
Trovagene, Inc. , a clinical-stage, oncology therapeutics company targeting cancers that are both highly prevalent and in need of new effective treatment options including colorectal, prostate and acute myeloid leukemia, today announced positive data...

08:00
Soliton, Inc., ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced positive...

07:00
A new animal study suggests affronEYE® saffron could help prevent the onset of glaucoma. The antioxidant and anti-inflammatory characteristics of this potent saffron extract, developed by Pharmactive Biotech Products, S.L., demonstrated an ability to...

07:00
Oncolytics Biotech® Inc. , currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced that a poster presentation highlighting statistically significant data identifying CEACAM6 as a prospective biomarker for...

06:45
Eli Lilly and Company and Incyte announced today that baricitinib met the primary endpoint in BREEZE-AD4, an investigational Phase 3, randomized, placebo-controlled study evaluating the safety and efficacy of baricitinib in combination with topical...

05:00
The methods by which a clinical trials recruitment agency operates are ever-changing. While the eventual goal ? to promote engagement and recruit participants for clinical trials ? remains the same, the steps will change in different ways. Everything...

04:01
For the benefit of healthcare professionals, medical researchers and the public, Elsevier, a global information analytics business specializing in science and health, has created a Novel Coronavirus Information Center with free information in English...

00:00
Epygenix Therapeutics, Inc., a privately held biopharmaceutical company developing precision medicine for Dravet Syndrome, announced today that the Company successfully completed a Phase I, Placebo-Controlled, Double-Blind, 2-Period Study to assess...


25 january 2020

09:30
Taiho Oncology, Inc. announced today the presentation of a pooled analysis for hematologic adverse events of the global Phase III TAGS and RECOURSE trials evaluating LONSURF® (trifluridine and tipiracil) in patients with metastatic colorectal cancer...


24 january 2020

18:52
BERG, a biopharmaceutical company that merges biology with technology to map and identify drivers of diseases, today announced the presentation of initial results from a Phase 2 clinical trial at the Gastrointestinal Cancer Symposium (ASCO-GI), being...

17:51
University Hospitals Seidman Cancer Center treated its first patient in a new clinical trial to validate the groundbreaking effects of the poliovirus on glioblastoma (GBM), a deadly Grade IV cancer of the brain. UH is the only Midwest site...

14:20
Stress is the health epidemic of the 21st Century, according to the World Health Organization, and one in four people will experience mental illness in their lives, costing an estimated $6 trillion by 2030. Employers and health plans have found a...

12:37
Koneksa Health, the leader in developing and implementing patient-focused digital biomarkers for drug development, along with Merck & Co, Inc. announced the publication of a peer-reviewed Phase I clinical trial evaluating the accuracy and...

09:30
ATAI Life Sciences AG ("ATAI" or the "Company"), a global biotech platform that envisions an end to mental illnesses, today announced an investment in two separate joint ventures (JV) with DemeRx, a clinical stage pharmaceutical company focused on...

09:29
Lipidor AB  today reports positive topline results of its AKP01 Phase III clinical study, using calcipotriol spray against mild to moderate plaque psoriasis. The randomised 277-patient study achieved its primary endpoint demonstrating therapeutic...

09:00
Abbott today announced it received approval from the U.S. Food and Drug Administration (FDA) for a new, expanded indication for the company's Infinitytm Deep Brain Stimulation (DBS) system to include targeting of an area of the brain called the...

08:00
Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced the receipt of formal acceptance from the U.S. Food and Drug Administration (FDA) to proceed with its CNM-Au8 as one of the first three drug regimens in the HEALEY...

07:44
Isofol Medical AB (publ), today announced that the first patient in Australia has initiated treatment in the global Phase 3 AGENT study. Isofol's drug candidate arfolitixorin is being evaluated in the first line of treatment of metastatic colorectal...

05:00
A company's website is regarded as a reflection of the company itself. In other words, the more presentable a site is, the more trust a brand will be instilled with. This logic is carried throughout every aspect of a site, from its overall structure...

01:04
CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) recently announced that it has dosed the first patient in Australia in a clinical trial of CS1001, an investigational PD-L1 inhibitor developed by CStone, in combination with regorafenib,...


23 january 2020

19:00
In the largest genetic sequencing study of autism spectrum disorder (ASD) to date, researchers have identified 102 genes associated with risk for autism. The study also shows significant progress towards teasing apart the genes associated with ASD...

17:00
Changing the microenvironment of tumors to increase the immune system's response to them has been the goal of countless research and clinical studies including the most recent use of checkpoint inhibitory antibodies. The majority of patients have...

09:15
Inovio Pharmaceuticals, Inc. today announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Inovio a grant of up to $9 million to develop a vaccine against the recently emerged strain of coronavirus (2019-nCoV) that has...

09:00
Abbott announced positive results from a prospective, multicenter study, providing the scientific basis for the company's Proclaimtm XR recharge-free neurostimulation system for people living with chronic pain. Data from the BurstDR micrOdosing...

09:00
A peer-reviewed multi-disciplinary consensus manuscript published in the January edition of Clinical Microbiology Reviews (CMR) concluded that the national benchmark for blood culture contamination should be reduced from the current 3% 'acceptable'...

08:45
Since The Chinese authorities identified a new type of coronavirus, (novel coronavirus 2019-nCoV) from Wuhan, Hubei Province, China, which was isolated on 7 January 2020, the World Health Organization (WHO), governments and laboratories around the...

08:01
WCG (WIRB-Copernicus Group), the world's leading provider of solutions that measurably improve the quality and efficiency of clinical trials, today announced its acquisition of Statistics Collaborative, Inc. Based in Washington, DC, Statistics...

07:00
Leap Therapeutics, Inc. today presented updated clinical data from its recently completed Phase 1/2 clinical trial of DKN-01 in patients with advanced or recurrent esophagogastric cancer (EGC) at the 2020 ASCO GI annual meeting. Updated response and...

04:06
iOnctura B.V., a clinical stage biopharmaceutical company, developing a pipeline of next generation molecules targeting cancer and fibrosis, announces today the closing of a EUR 15 million Series A financing. The financing was led by INKEF Capital...

01:00
SOUTH PLAINFIELD, N.J., Jan. 23, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. today announced positive topline results from part 2 of FIREFISH demonstrating that the study met its primary endpoint of proportion of infants who are sitting without...


22 january 2020

20:52
Ascletis Pharma Inc. (Ascletis, 1672.HK) announces today the approval for ASC22 to conduct clinical trials in chronic hepatitis B patients in China from China's National Medical Products Administration. ASC22 is a first-in-class, subcutaneously...

19:01
The largest and most authoritative research trial of its kind has confirmed that Allen Carr's Easyway (ACE) is now a clinically proven, highly effective drug-free alternative to nicotine patches, gum, and e-cigarettes and the study should pave the...

16:15
Biohaven Pharmaceutical Holding Company Ltd. ("Biohaven" or the "Company"), a biopharmaceutical company with multiple late-stage neuroscience drug candidates in development, announced today that the U.S. Food and Drug Administration (FDA) has...

11:00
The National Advertising Division (NAD) recommended that PRN Physician Recommended Nutraceuticals discontinue certain challenged product and ingredient claims for its nuretin medical food, following a challenge by the Council for Responsible...

09:07
A newly published article in The Journal of Radiation Oncology1 from lead author Dr. Anesa Ahamad, a radiation oncologist at 21st Century Oncology, reports that patients with early-stage voice box cancer who receive radiotherapy over a 5 ½-week...

1 2 3 4 5 6 7 8 9 10